Anavex Life Sciences Corp. (AVXL) NASDAQ

8.91

+0.04(+0.45%)

Updated at February 05 03:00PM

Currency In USD

Valuation

Market Cap474.1M
Enterprise Value341.91M
P/E Ratio-17.13
PEG Ratio-0.67
Price/Sales Ratio0
Price/Book Ratio6.12
Enterprise/Revenue0
Enterprise/EBITDA-29.71

Fiscal Year

Fiscal YearSeptember 30, 2024
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.33

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA0
Net Income-43M
Diluted EPS-0.52

Balance Sheet

Total Cash132.19M
Total Cash/Share1.59
Total Debt0
Total Debt/Equity0
Current Ratio8.86
Book Value Per Share1.45

Price History

52-Week Change65.49
52-Week High14.44
52-Week Low3.25
Moving Average 50 Days9.84
Moving Average 200 Days6.43

Statistics

Average Volume1.92M
Shares Outstanding84.82M
% Held by Institutions32.98

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateOctober 07, 2015